This work presents the results of a methodological transfer from remote sensing to healthcare, adapting AMBER -- a transformer-based model originally designed for multiband images, such as hyperspectral data -- to the task of 3D medical datacube segmentation. In this study, we use the AMBER architecture with Adaptive Fourier Neural Operators (AFNO) in place of the multi-head self-attention mechanism. While existing models rely on various forms of attention to capture global context, AMBER-AFNO achieves this through frequency-domain mixing, enabling a drastic reduction in model complexity. This design reduces the number of trainable parameters by over 80% compared to UNETR++, while maintaining a FLOPs count comparable to other state-of-the-art architectures. Model performance is evaluated on two benchmark 3D medical datasets -- ACDC and Synapse -- using standard metrics such as Dice Similarity Coefficient (DSC) and Hausdorff Distance (HD), demonstrating that AMBER-AFNO achieves competitive or superior accuracy with significant gains in training efficiency, inference speed, and memory usage.

Alzheimer's disease (AD) progression follows a complex continuum from normal cognition (NC) through mild cognitive impairment (MCI) to dementia, yet most deep learning approaches oversimplify this into discrete classification tasks. This study introduces M$^3$AD, a novel multi-task multi-gate mixture of experts framework that jointly addresses diagnostic classification and cognitive transition modeling using structural MRI. We incorporate three key innovations: (1) an open-source T1-weighted sMRI preprocessing pipeline, (2) a unified learning framework capturing NC-MCI-AD transition patterns with demographic priors (age, gender, brain volume) for improved generalization, and (3) a customized multi-gate mixture of experts architecture enabling effective multi-task learning with structural MRI alone. The framework employs specialized expert networks for diagnosis-specific pathological patterns while shared experts model common structural features across the cognitive continuum. A two-stage training protocol combines SimMIM pretraining with multi-task fine-tuning for joint optimization. Comprehensive evaluation across six datasets comprising 12,037 T1-weighted sMRI scans demonstrates superior performance: 95.13% accuracy for three-class NC-MCI-AD classification and 99.15% for binary NC-AD classification, representing improvements of 4.69% and 0.55% over state-of-the-art approaches. The multi-task formulation simultaneously achieves 97.76% accuracy in predicting cognitive transition. Our framework outperforms existing methods using fewer modalities and offers a clinically practical solution for early intervention. Code: https://github.com/csyfjiang/M3AD.

Hepatocellular carcinoma (HCC) ultrasound screening encounters challenges related to accuracy and the workload of radiologists. This retrospective, multicenter study assessed four artificial intelligence (AI) enhanced strategies using 21,934 liver ultrasound images from 11,960 patients to improve HCC ultrasound screening accuracy and reduce radiologist workload. UniMatch was used for lesion detection and LivNet for classification, trained on 17,913 images. Among the strategies tested, Strategy 4, which combined AI for initial detection and radiologist evaluation of negative cases in both detection and classification phases, outperformed others. It not only matched the high sensitivity of original algorithm (0.956 vs. 0.991) but also improved specificity (0.787 vs. 0.698), reduced radiologist workload by 54.5%, and decreased both recall and false positive rates. This approach demonstrates a successful model of human-AI collaboration, not only enhancing clinical outcomes but also mitigating unnecessary patient anxiety and system burden by minimizing recalls and false positives.

Accurate and early diagnosis of Alzheimer's Disease (AD) is crucial for timely interventions and treatment advancement. Functional Magnetic Resonance Imaging (fMRI), measuring brain blood-oxygen level changes over time, is a powerful AD-diagnosis tool. However, current fMRI-based AD diagnosis methods rely on noise-susceptible time-domain features and focus only on synchronous brain-region interactions in the same time phase, neglecting asynchronous ones. To overcome these issues, we propose Frequency-Time Fusion Graph Neural Network (FTF-GNN). It integrates frequency- and time-domain features for robust AD classification, considering both asynchronous and synchronous brain-region interactions. First, we construct a fully connected hypervariate graph, where nodes represent brain regions and their Blood Oxygen Level-Dependent (BOLD) values at a time series point. A Discrete Fourier Transform (DFT) transforms these BOLD values from the spatial to the frequency domain for frequency-component analysis. Second, a Fourier-based Graph Neural Network (FourierGNN) processes the frequency features to capture asynchronous brain region connectivity patterns. Third, these features are converted back to the time domain and reshaped into a matrix where rows represent brain regions and columns represent their frequency-domain features at each time point. Each brain region then fuses its frequency-domain features with position encoding along the time series, preserving temporal and spatial information. Next, we build a brain-region network based on synchronous BOLD value associations and input the brain-region network and the fused features into a Graph Convolutional Network (GCN) to capture synchronous brain region connectivity patterns. Finally, a fully connected network classifies the brain-region features. Experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset demonstrate the method's effectiveness: Our model achieves 91.26% accuracy and 96.79% AUC in AD versus Normal Control (NC) classification, showing promising performance. For early-stage detection, it attains state-of-the-art performance in distinguishing NC from Late Mild Cognitive Impairment (LMCI) with 87.16% accuracy and 93.22% AUC. Notably, in the challenging task of differentiating LMCI from AD, FTF-GNN achieves optimal performance (85.30% accuracy, 94.56% AUC), while also delivering competitive results (77.40% accuracy, 91.17% AUC) in distinguishing Early MCI (EMCI) from LMCI-the most clinically complex subtype classification. These results indicate that leveraging complementary frequency- and time-domain information, along with considering asynchronous and synchronous brain-region interactions, can address existing approach limitations, offering a robust neuroimaging-based diagnostic solution.

Vertebral compression fractures (VCFs) are the most prevalent skeletal manifestations of osteoporosis in cancer patients. Yet, they are frequently missed or not reported in routine clinical radiology, adversely impacting patient outcomes and quality of life. This study evaluates the diagnostic performance of a deep-learning (DL)-based application and its potential to reduce the miss rate of incidental VCFs in a high-risk cancer population. We retrospectively analysed thoraco-abdomino-pelvic (TAP) CT scans from 1556 patients with stage IV cancer collected consecutively over a 4-month period (September-December 2023) in a tertiary cancer center. A DL-based application flagged cases positive for VCFs, which were subsequently reviewed by two expert radiologists for validation. Additionally, grade 3 fractures identified by the application were independently assessed by two expert interventional radiologists to determine their eligibility for vertebroplasty. Of the 1556 cases, 501 were flagged as positive for VCF by the application, with 436 confirmed as true positives by expert review, yielding a positive predictive value (PPV) of 87%. Common causes of false positives included sclerotic vertebral metastases, scoliosis, and vertebrae misidentification. Notably, 83.5% (364/436) of true positive VCFs were absent from radiology reports, indicating a substantial non-report rate in routine practice. Ten grade 3 fractures were overlooked or not reported by radiologists. Among them, 9 were deemed suitable for vertebroplasty by expert interventional radiologists. This study underscores the potential of DL-based applications to improve the detection of VCFs. The analyzed tool can assist radiologists in detecting more incidental vertebral fractures in adult cancer patients, optimising timely treatment and reducing associated morbidity and economic burden. Moreover, it might enhance patient access to interventional treatments such as vertebroplasty. These findings highlight the transformative role that DL can play in optimising clinical management and outcomes for osteoporosis-related VCFs in cancer patients.

Accurate and efficient brain tumor segmentation remains a critical challenge in neuroimaging due to the heterogeneous nature of tumor subregions and the high computational cost of volumetric inference. In this paper, we propose EfficientGFormer, a novel architecture that integrates pretrained foundation models with graph-based reasoning and lightweight efficiency mechanisms for robust 3D brain tumor segmentation. Our framework leverages nnFormer as a modality-aware encoder, transforming multi-modal MRI volumes into patch-level embeddings. These features are structured into a dual-edge graph that captures both spatial adjacency and semantic similarity. A pruned, edge-type-aware Graph Attention Network (GAT) enables efficient relational reasoning across tumor subregions, while a distillation module transfers knowledge from a full-capacity teacher to a compact student model for real-time deployment. Experiments on the MSD Task01 and BraTS 2021 datasets demonstrate that EfficientGFormer achieves state-of-the-art accuracy with significantly reduced memory and inference time, outperforming recent transformer-based and graph-based baselines. This work offers a clinically viable solution for fast and accurate volumetric tumor delineation, combining scalability, interpretability, and generalization.

Predicting brain age from T1-weighted MRI is a promising marker for understanding brain aging and its associated conditions. While deep learning models have shown success in reducing the mean absolute error (MAE) of predicted brain age, concerns about robust and accurate generalization in new data limit their clinical applicability. The large number of trainable parameters, combined with limited medical imaging training data, contributes to this challenge, often resulting in a generalization gap where there is a significant discrepancy between model performance on training data versus unseen data. In this study, we assess a deep model, SFCN-reg, based on the VGG-16 architecture, and address the generalization gap through comprehensive preprocessing, extensive data augmentation, and model regularization. Using training data from the UK Biobank, we demonstrate substantial improvements in model performance. Specifically, our approach reduces the generalization MAE by 47% (from 5.25 to 2.79 years) in the Alzheimer's Disease Neuroimaging Initiative dataset and by 12% (from 4.35 to 3.75 years) in the Australian Imaging, Biomarker and Lifestyle dataset. Furthermore, we achieve up to 13% reduction in scan-rescan error (from 0.80 to 0.70 years) while enhancing the model's robustness to registration errors. Feature importance maps highlight anatomical regions used to predict age. These results highlight the critical role of high-quality preprocessing and robust training techniques in improving accuracy and narrowing the generalization gap, both necessary steps toward the clinical use of brain age prediction models. Our study makes valuable contributions to neuroimaging research by offering a potential pathway to improve the clinical applicability of deep learning models.

Double-dose contrast-enhanced brain imaging improves tumor delineation and detection of occult metastases but is limited by concerns about gadolinium-based contrast agents' effects on patients and the environment. The purpose of this study was to test the benefit of a deep learning-based contrast signal amplification in true single-dose T1-weighted (T-SD) images creating artificial double-dose (A-DD) images for metastasis detection in brain magnetic resonance imaging. In this prospective, multicenter study, a deep learning-based method originally trained on noncontrast, low-dose, and T-SD brain images was applied to T-SD images of 30 participants (mean age ± SD, 58.5 ± 11.8 years; 23 women) acquired externally between November 2022 and June 2023. Four readers with different levels of experience independently reviewed T-SD and A-DD images for metastases with 4 weeks between readings. A reference reader reviewed additionally acquired true double-dose images to determine any metastases present. Performances were compared using Mid-p McNemar tests for sensitivity and Wilcoxon signed rank tests for false-positive findings. All readers found more metastases using A-DD images. The 2 experienced neuroradiologists achieved the same level of sensitivity using T-SD images (62 of 91 metastases, 68.1%). While the increase in sensitivity using A-DD images was only descriptive for 1 of them (A-DD: 65 of 91 metastases, +3.3%, P = 0.424), the second neuroradiologist benefited significantly with a sensitivity increase of 12.1% (73 of 91 metastases, P = 0.008). The 2 less experienced readers (1 resident and 1 fellow) both found significantly more metastases on A-DD images (resident, T-SD: 61.5%, A-DD: 68.1%, P = 0.039; fellow, T-SD: 58.2%, A-DD: 70.3%, P = 0.008). They were therefore able to use A-DD images to increase their sensitivity to the neuroradiologists' initial level on regular T-SD images. False-positive findings did not differ significantly between sequences. However, readers showed descriptively more false-positive findings on A-DD images. The benefit in sensitivity particularly applied to metastases ≤5 mm (5.7%-17.3% increase in sensitivity). A-DD images can improve the detectability of brain metastases without a significant loss of precision and could therefore represent a potentially valuable addition to regular single-dose brain imaging.

The rapid evolution of artificial intelligence, especially in large language models (LLMs), has significantly impacted various domains, including healthcare. In chest X-ray (CXR) analysis, previous studies have employed LLMs, but with limitations: either underutilizing the LLMs' capability for multitask learning or lacking clinical accuracy. This article presents M4CXR, a multimodal LLM designed to enhance CXR interpretation. The model is trained on a visual instruction-following dataset that integrates various task-specific datasets in a conversational format. As a result, the model supports multiple tasks such as medical report generation (MRG), visual grounding, and visual question answering (VQA). M4CXR achieves state-of-the-art clinical accuracy in MRG by employing a chain-of-thought (CoT) prompting strategy, in which it identifies findings in CXR images and subsequently generates corresponding reports. The model is adaptable to various MRG scenarios depending on the available inputs, such as single-image, multiimage, and multistudy contexts. In addition to MRG, M4CXR performs visual grounding at a level comparable to specialized models and demonstrates outstanding performance in VQA. Both quantitative and qualitative assessments reveal M4CXR's versatility in MRG, visual grounding, and VQA, while consistently maintaining clinical accuracy.

The hippocampal-to-ventricle ratio (HVR) is a biomarker of medial temporal atrophy, particularly useful in the assessment of neurodegeneration in diseases such as Alzheimer's disease (AD). To minimize subjectivity and inter-rater variability, an automated, accurate, precise, and reliable segmentation technique for the hippocampus (HC) and surrounding cerebro-spinal fluid (CSF) filled spaces-such as the temporal horns of the lateral ventricles-is essential. We trained and evaluated three automated methods for the segmentation of both HC and CSF (Multi-Atlas Label Fusion (MALF), Nonlinear Patch-Based Segmentation (NLPB), and a Convolutional Neural Network (CNN)). We then evaluated these methods, including the widely used FreeSurfer technique, using baseline T1w MRIs of 1641 participants from the AD Neuroimaging Initiative study with various degree of atrophy associated with their cognitive status on the spectrum from cognitively healthy to clinically probable AD. Our gold standard consisted in manual segmentation of HC and CSF from 80 cognitively healthy individuals. We calculated HC volumes and HVR and compared all methods in terms of segmentation reliability, similarity across methods, sensitivity in detecting between-group differences and associations with age, scores of the learning subtest of the Rey Auditory Verbal Learning Test (RAVLT) and the Alzheimer's Disease Assessment Scale 13 (ADAS13) scores. Cross validation demonstrated that the CNN method yielded more accurate HC and CSF segmentations when compared to MALF and NLPB, demonstrating higher volumetric overlap (Dice Kappa = 0.94) and correlation (rho = 0.99) with the manual labels. It was also the most reliable method in clinical data application, showing minimal failures. Our comparisons yielded high correlations between FreeSurfer, CNN and NLPB volumetric values. HVR yielded higher control:AD effect sizes than HC volumes among all segmentation methods, reinforcing the significance of HVR in clinical distinction. The positive association with age was significantly stronger for HVR compared to HC volumes on all methods except FreeSurfer. Memory associations with HC volumes or HVR were only significant for individuals with mild cognitive impairment. Finally, the HC volumes and HVR showed comparable negative associations with ADAS13, particularly in the mild cognitive impairment cohort. This study provides an evaluation of automated segmentation methods centered to estimate HVR, emphasizing the superior performance of a CNN-based algorithm. The findings underscore the pivotal role of accurate segmentation in HVR calculations for precise clinical applications, contributing valuable insights into medial temporal lobe atrophy in neurodegenerative disorders, especially AD.